In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Asensus Surgical Inc (AMEX: ASXC) closed at $0.25 up 3.32% from its previous closing price of $0.24. In other words, the price has increased by $3.32 from its previous closing price. On the day, 0.61 million shares were traded. ASXC stock price reached its highest trading level at $0.25 during the session, while it also had its lowest trading level at $0.239.
Ratios:
For a deeper understanding of Asensus Surgical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.31 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.14.
On September 08, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $1.50.
On May 26, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.H.C. Wainwright initiated its Buy rating on May 26, 2021, with a $4 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 14 ’23 when Starling William N JR bought 18,134 shares for $0.28 per share. The transaction valued at 5,078 led to the insider holds 39,134 shares of the business.
Starling William N JR sold 18,134 shares of ASXC for $5,078 on Dec 14 ’23. The Director now owns 0 shares after completing the transaction at $0.28 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASXC now has a Market Capitalization of 67724512 and an Enterprise Value of 52339604. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.89 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 6.102 whereas that against EBITDA is -0.703.
Stock Price History:
Over the past 52 weeks, ASXC has reached a high of $0.70, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -9.37%, while the 200-Day Moving Average is calculated to be -15.46%.
Shares Statistics:
For the past three months, ASXC has traded an average of 1.62M shares per day and 1224590 over the past ten days. A total of 271.99M shares are outstanding, with a floating share count of 266.48M. Insiders hold about 1.95% of the company’s shares, while institutions hold 9.76% stake in the company. Shares short for ASXC as of 1713139200 were 16511511 with a Short Ratio of 10.20, compared to 1710460800 on 17009558. Therefore, it implies a Short% of Shares Outstanding of 16511511 and a Short% of Float of 6.17.
Earnings Estimates
At present, 2.0 analysts are actively evaluating the performance of Asensus Surgical Inc (ASXC) in the stock market.On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.05, while EPS last year was -$0.09. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.18 and -$0.19 for the fiscal current year, implying an average EPS of -$0.18. EPS for the following year is -$0.14, with 2.0 analysts recommending between -$0.13 and -$0.16.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $1.2M this quarter.It ranges from a high estimate of $1.3M to a low estimate of $1.09M. As of the current estimate, Asensus Surgical Inc’s year-ago sales were $976kFor the next quarter, 2 analysts are estimating revenue of $1.28M. There is a high estimate of $1.3M for the next quarter, whereas the lowest estimate is $1.26M.
A total of 2 analysts have provided revenue estimates for ASXC’s current fiscal year. The highest revenue estimate was $14.29M, while the lowest revenue estimate was $10.3M, resulting in an average revenue estimate of $12.3M. In the same quarter a year ago, actual revenue was $8.58MBased on 2 analysts’ estimates, the company’s revenue will be $22.21M in the next fiscal year. The high estimate is $31.52M and the low estimate is $12.9M.
